Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.
As Mapp's products transition to clinical evaluation, ownership and development responsibilities are transferred to LeafBio, Mapp's commercialization partner.
Mapp Biopharmaceutical, Inc.
6160 Lusk Blvd. # C105
San Diego, CA 92121
phone: 858 625 0335
fax: 800 372 2176
|©2012 Mapp Biopharmaceutical, Inc. All rights reserved.|